Innate Pharma buy metanicnor
Start price
07.09.14
/
50%
€8.63
Target price
09.03.15
€10.50
Performance (%)
19.99%
End price
09.03.15
€10.35
Summary
This prediction ended on 09.03.15 with a price of €10.35. The prediction had a final performance of 19.99%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innate Pharma | 6.073% | 6.073% | -21.163% | -46.091% |
| iShares Core DAX® | -0.100% | 3.931% | 32.407% | 80.117% |
| iShares Nasdaq 100 | 1.827% | 5.670% | 10.821% | 64.325% |
| iShares Nikkei 225® | -0.370% | 0.109% | -1.143% | 17.319% |
| iShares S&P 500 | 1.185% | 4.668% | 8.117% | 44.476% |
Comments by metanicnor for this prediction
In the thread Innate Pharma diskutieren
IPH Kauf
eines der wenigen Biotech-Unternehmen in der Welt auf der angeborenen Immunität positioniert
das Geld wird es ermöglichen, halten die Ende 2017
(Laufzeit überschritten)